3 min read
Cleerly Revealed What Other Tests for Coronary Artery Disease Couldn’t
"It's very scary because I had a lot of patients and even friends and neighbors that had heart attacks, and we thought...
Connect With Us
Artificial Intelligence & Machine Learning Hands-On WorkshopJoin us by registering here |
||
10:00 AM - 10:30 AM PST | From Dark to Bright: Leveraging Coronary CT Angiography Findings to Improve Diagnosis, Risk Stratification, Treatment Decision Making and Longitudinal Disease Tracking | James Min, MD, MSCCT |
10:30 AM - 12:30 AM PST | Sponsored workshop: AI-QCT Coronary Analysis Workshop | James Min, MD, MSCCT Jay Earls, MD, FSCCT |
Scientific Sessions and ExhibitsVisit Cleerly at booth 103 |
![]() |
CONFIRM2 Investigators Meeting & ReceptionBy invitation only |
Learn more about Cleerly's AI-enabled technology that identifies the presence, type, and amount of heart disease which improves understanding of heart attack risk, and empowers clinicians to personalize treatment for better outcomes.
If you missed our recent SCCT webinar, watch on-demand to learn how to use these stages and thresholds, which are based on evidence from coronary angiography stenosis and fractional flow reserve (FFR) data, to determine precision medical therapy based upon an individual's atherosclerotic phenotype.
May 23, 2023 by Cleerly
Oct 18, 2022 by Cleerly
Jun 8, 2022 by Cleerly